MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma
Background: Hepatic resection, radiofrequency ablation (RF), and liver transplantation (LT) represent the only available curative treatments for early stage hepatocellular carcinoma (HCC). Various studies showed that the 5-year overall survival (OS) rate reaches ∼70% after resection and ∼60% after R...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2022-12-01
|
| Colecção: | Technology in Cancer Research & Treatment |
| Acesso em linha: | https://doi.org/10.1177/15330338221132924 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|